Research Paper Volume 9, Issue 10 pp 2117—2136

Identification of polymorphisms in cancer patients that differentially affect survival with age

Figure 4. Kaplan Meier survival estimates of overall survival for FoxO pathway among the Framingham Heart Study according to a dominant genotype model, comparing patients with a high number of wild types to those with a low number of wild types. The full data set indicates all individuals diagnosed with cancer over the age of 50; and subsequently each age category is the individuals diagnosed with cancer in that particular age category. Solid lines indicate survival curve, dashed line indicates 95% confidence interval.